Sage Journals: Discover world-class research

Abstract

BACKGROUND:

The morphological alterations of small pulmonary vessels measured by computed tomography (CT) is increasingly used in evaluation of suspected pulmonary hypertension (PH).

OBJECTIVE:

To investigate the significance alterations of quantitative assessment of small pulmonary vessels on chest CT in distinguishing different types of PH and their severity.

METHODS:

We retrospectively analyzed a dataset of 120 healthy controls (HCs) and 91 PH patients, including 34 patients with connective tissue diseases-related PH (CTD-PH), 26 patients with idiopathic pulmonary arterial hypertension (iPAH), and 31 patients with chronic obstructive pulmonary disease-related PH (COPD-PH). The CTD-PH patients were divided into mild to moderate PH (CTD-LM-PH) group (n = 17) and severe PH (CTD-S-PH) group (n = 17). A total of 53 CTD patients without PH (CTD-nPH) were enrolled for comparison with the CTD-PH. We measured the cross-sectional area of small pulmonary vessels < 5 mm² (%CSA_<5) and between 5–10 mm² (%CSA_5–10) as a percentage of total lung area among the populations included above and compared %CSA in different types of PH groups and HCs group. The mean pulmonary arterial pressure (mPAP) was measured by right heart catheterization.

RESULTS:

The %CSA_5–10 of COPD-PH, CTD-PH, and iPAH patients increased (0.21±0.09, 0.49±0.20 and 0.61±0.20, p < 0.02) sequentially, while the %CSA_<5 of CTD-PH, iPAH, and COPD-PH patients decreased (0.79±0.65, 0.65±0.38 and 0.52±0.27, p < 0.05) sequentially. The %CSA_5–10 was significantly higher in CTD-S-PH patients than CTD-LM-PH patients and CTD-nPH patients (0.51±0.21, 0.31±0.15 and 0.28±0.12, p < 0.01). The %CSA_5–10 was positively correlated with mPAP in the CTD-PH group.

CONCLUSIONS:

The quantitative parameters %CSA_<5 and %CSA_5–10 assessed by chest CT are useful for distinguishing different types of PH. In addition, the %CSA_5–10 can provide information for identification of CTD-PH severity.

Keywords

Small pulmonary vessels pulmonary hypertension (PH)computed tomography (CT)PH severity classification

Get full access to this article

View all access options for this article.

References

Galie

, Humbert

, Vachiery

J.L.

, et al., ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), Eur Heart J 37 (1) (2016), 67–119.

Zhao

, Wang

, Liu

, et al., Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China, Int J Cardiol 236 (2017), 432–437.

Siddiqui

, Rajagopal

, Brucker

, et al., Clinical and echocardiographic predictors of outcomes in patients with pulmonary hypertension, Am J Cardiol 122(5) (2018), 872–878.

Coste

, Dournes

, Dromer

, et al., CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension, Thorax 71(9) (2016), 830–837.

Freed

B.H.

, Collins

J.D.

, Francois

C.J.

, et al., MR and CT Imaging for the Evaluation of Pulmonary Hypertension, JACC Cardiovasc Imaging 9(6) (2016), 715–732.

Ley

, Grunig

, Kiely

D.G.

, et al., Computed tomography and magnetic resonance imaging of pulmonary hypertension: Pulmonary vessels and right ventricle, , J Magn Reson Imaging 32(6) (2010), 1313–1324.

Mahammedi

, Oshmyansky

, Hassoun

P.M.

, et al., Pulmonary artery measurements in pulmonary hypertension: the role of computed tomography, J Thorac Imaging 28(2) (2013), 96–103.

Coste

, Benlala

, Dournes

, et al., Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension, Int J Chron Obstruct Pulmon Dis 14 (2019), 381–389.

Shimizu

, Tsujino

, Sato

, et al., Performance of computed tomography-derived pulmonary vasculature metrics in the diagnosis and haemodynamic assessment of pulmonary arterial hypertension, Eur J Radiol 96 (2017), 31–38.

10.

Siegel

, Bleicher

, Gordon

M.K.

, et al., Computed tomography pulmonary angiogram dynamic parameter correlation with pulmonary pressure and pulmonary hypertension etiologies, J Comput Assist Tomogr 41(5) (2017), 779–783.

11.

Matsuoka

, Washko

G.R.

, Yamashiro

, et al., National emphysema treatment trial research, pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema, Am J Respir Crit Care Med 181(3) (2010), 218–225.

12.

Matsuoka

, Washko

G.R.

, Dransfield

M.T.

, et al., Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation, Acad Radiol 17(1) (2010), 93–99.

13.

Uejima

, Matsuoka

, Yamashiro

, et al., Quantitative computed tomographic measurement of a cross-sectional area of a small pulmonary vessel in nonsmokers without airflow limitation, Jpn J Radiol 29(4) (2011), 251–255.

14.

McLaughlin

V.V.

, Shah

S.J.

, Souza

, et al., Management of pulmonary arterial hypertension, J Am Coll Cardiol 65(18) (2015), 1976–1997.

15.

Brown

J.W.

, Heath

and Whitaker

Idiopathic pulmonary hypertension, Br Heart J 19(1) (1957), 83–92.

16.

Shimoda

L.A.

and Laurie

S.S.

Vascular remodeling in pulmonary hypertension, J Mol Med (Berl) 91(3) (2013), 297–309.

17.

Tuder

R.M.

, Archer

S.L.

, Dorfmuller

, et al., Relevant issues in the pathology and pathobiology of pulmonary hypertension, J Am Coll Cardiol 62 (2013), D4–12.

18.

Pietra

G.G.

, Capron

, Stewart

, et al., Pathologic assessment of vasculopathies in pulmonary hypertension, J Am Coll Cardiol 43 (2004), 25S–32S.

19.

Zanatta

, Polito

, Famoso

, et al., Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment, Exp Biol Med (Maywood) 244(2) (2019), 120–131.

20.

Rabinovitch

, Guignabert

, Humbert

, et al., Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension, Circ Res 115(1) (2014), 165–75.

21.

Thenappan

, Ormiston

M.L.

, Ryan

J.J.

, et al., Pulmonary arterial hypertension: pathogenesis and clinical management, BMJ 360 (2018), j5492.

22.

Thompson

A.A.R.

and Lawrie

Targeting vascular remodeling to treat pulmonary arterial hypertension, Trends Mol Med 23(1) (2017), 31–45.

23.